CELU — Celularity Cashflow Statement
0.000.00%
Last trade - 00:00- $65.78m
- $100.52m
- $17.98m
- 21
- 45
- 79
- 45
Annual cashflow statement for Celularity, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.001 | 2.51 | -2.63 | -100 | 14.2 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | -3.75 | -1.78 | -6.36 | -144 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.001 | 0.136 | 3.23 | -11.1 | -18 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.001 | -1.1 | -1.18 | -110 | -138 |
| Capital Expenditures | — | — | — | -6.2 | -5.24 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -287 | 0.579 | 0.3 | 0 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -287 | 0.579 | -5.9 | -5.24 |
| Financing Cash Flow Items | 0 | -0.511 | — | 97.9 | 26.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.025 | 289 | — | 98.6 | 120 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.025 | 0.892 | -0.602 | -17.4 | -23.3 |